AusPAR: Liraglutide

Australian Public Assessment Report

AusPAR

AusPAR: Liraglutide [PDF, 1.5 MB]

AusPAR: Liraglutide [Word, 3.73 MB]

Attachment: Product Information: Liraglutide [PDF, 517.38 KB]

Attachment: Product Information: Liraglutide [Word, 548.8 KB]

Attachment: Extract from Clinical Evaluation Report: Liraglutide [PDF, 2.48 MB]

Attachment: Extract from Clinical Evaluation Report: Liraglutide [Word, 6.66 MB]

Device/Product Name

Saxenda

Active ingredients

Liraglutide

AusPAR Date

23 March 2016

Published

6 April 2016

Submission Number

PM-2014-01472-1-5

Submission Type

Extension of indications

Decision

Approved